Nutritional safety and suitability of a specific protein hydrolysate derived from a whey protein concentrate and used in an infant formula and follow-on formula manufactured from hydrolysed protein by FrieslandCampina Nederland B.V
| dc.contributor.author | EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) | |
| dc.contributor.institution | University of Aberdeen.Rowett Institute | en |
| dc.contributor.institution | University of Aberdeen.Medical Sciences - Cardiovascular Group | en |
| dc.date.accessioned | 2023-08-09T15:44:01Z | |
| dc.date.available | 2023-08-09T15:44:01Z | |
| dc.date.issued | 2023-07-18 | |
| dc.description | © 2023 European Food Safety Authority. EFSA Journal published by Wiley‐VCH GmbH on behalf of European Food Safety Authority. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 1092264 | |
| dc.identifier | 272228694 | |
| dc.identifier | ff03edb5-2183-4cc8-b20a-96394a6402c3 | |
| dc.identifier | 37469354 | |
| dc.identifier | 85165593300 | |
| dc.identifier.citation | EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) 2023, 'Nutritional safety and suitability of a specific protein hydrolysate derived from a whey protein concentrate and used in an infant formula and follow-on formula manufactured from hydrolysed protein by FrieslandCampina Nederland B.V', EFSA Journal, vol. 21, no. 7, e08063. https://doi.org/10.2903/j.efsa.2023.8063 | en |
| dc.identifier.doi | 10.2903/j.efsa.2023.8063 | |
| dc.identifier.iss | 7 | en |
| dc.identifier.issn | 1831-4732 | |
| dc.identifier.other | PubMedCentral: PMC10352869 | |
| dc.identifier.other | ORCID: /0000-0002-9275-9713/work/140426717 | |
| dc.identifier.uri | https://hdl.handle.net/2164/21454 | |
| dc.identifier.vol | 21 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | EFSA Journal | en |
| dc.subject | Protein hydrolysate | en |
| dc.subject | characterisation | en |
| dc.subject | infant formula | en |
| dc.subject | follow-on formula | en |
| dc.subject | nutritional safety | en |
| dc.subject | suitability | en |
| dc.subject | clinical trial | en |
| dc.title | Nutritional safety and suitability of a specific protein hydrolysate derived from a whey protein concentrate and used in an infant formula and follow-on formula manufactured from hydrolysed protein by FrieslandCampina Nederland B.V | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- NDA_etal_EFSAJ_Nutritional_Safety_And_VOR.pdf
- Size:
- 1.04 MB
- Format:
- Adobe Portable Document Format
